TheraCryf (LSE:TCF) Pretax Margin %: % (As of Sep. 2025)


What is TheraCryf Pretax Margin %?

TheraCryf LSE:TCF -8.51% Pretax Margin % is % as of Sep. 2025. The stock has 3 warning signs investors should review. Among 945 Biotechnology companies, TheraCryf ranks worse than 105820% on this metric.

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. TheraCryf's Pre-Tax Income for the six months ended in Sep. 2025 was £-1.31 Mil. TheraCryf's Revenue for the six months ended in Sep. 2025 was £0.00 Mil. Therefore, TheraCryf's pretax margin for the quarter that ended in Sep. 2025 was %.

The historical rank and industry rank for TheraCryf's Pretax Margin % or its related term are showing as below:


LSE:TCF's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -90.63
* Ranked among companies with meaningful Pretax Margin % only.

TheraCryf  (LSE:TCF) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

TheraCryf Pretax Margin % Related Terms

TheraCryf Pretax Margin % Historical Data

* Premium members only.

The historical data trend for TheraCryf's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

TheraCryf Pretax Margin % Chart

TheraCryf Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,656.19 0.00 -1,132.58 -900.51 0.00

TheraCryf Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -368.43 0.00 0.00 0.00 0.00

LSE:TCF vs VRTX, REGN, ALNY: Pretax Margin % Comparison

For the Biotechnology subindustry, TheraCryf's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TheraCryf Pretax Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TheraCryf's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where TheraCryf's Pretax Margin % falls into.


TheraCryf Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

TheraCryf's Pretax Margin for the fiscal year that ended in Mar. 2025 is calculated as

Pretax Margin=Pre-Tax Income (A: Mar. 2025 )/Revenue (A: Mar. 2025 )
=-2.085/0
= %

TheraCryf's Pretax Margin for the quarter that ended in Sep. 2025 is calculated as

Pretax Margin=Pre-Tax Income (Q: Sep. 2025 )/Revenue (Q: Sep. 2025 )
=-1.313/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pretax Margin % →
What does a Pretax Margin % of % mean?
TheraCryf (LSE:TCF) has a Pretax Margin % of % as of Sep. 2025. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on TheraCryf and its competitors. According to the industry distribution chart, TheraCryf ranks #999999 out of 945 companies in the Biotechnology industry.
Is TheraCryf's Pretax Margin % too high?
TheraCryf's current Pretax Margin % is %. Based on the distribution chart, TheraCryf ranks #999999 out of 945 companies in the Biotechnology industry, which is in the bottom quartile relative to peers.
How does TheraCryf's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, TheraCryf ranks #999999 out of 945 companies for Pretax Margin %. This places TheraCryf in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on TheraCryf and its competitors. TheraCryf's current Pretax Margin % is %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TheraCryf stock overvalued right now?
TheraCryf (LSE:TCF) has a current Pretax Margin % of %. The current Pretax Margin % is %. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For TheraCryf (LSE:TCF), the current Pretax Margin % is % as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TheraCryf Business Description

Address Congleton Road, Alderley Park, Nether Alderley, Cheshire, GBR, SK10 4TG
TheraCryf PLC is a clinical stage therapeutics company developing therapeutic candidates for behavioural brain disorders such as opioid and alcohol addiction, and acute/chronic fatigue. It focuses on data generation to support potential partnerships for its programs with mid-sized and large pharmaceutical companies. The company's pipeline includes Ox-1 - Substance Use Disorders (SUDs) / Anxiety, DAT - Fatigue and Narcolepsy, SFX-01, and SFX-01- Neurodevelopmental Disorders.